Peer Review History
| Original SubmissionJune 2, 2020 |
|---|
|
PONE-D-20-16670 Pain prevalence in hospitalized patients at a tertiary academic medical center: exploring severe persistent pain PLOS ONE Dear Dr. Wu, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ============================== Please submit your revised manuscript by Sep 28 2020 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: http://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols We look forward to receiving your revised manuscript. Kind regards, Yan Li Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1) Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2) Thank you for including your ethics statement: "The ethical committee/institutional review board (Institutional Review Board (II)107-B-08 Board Meeting) approved the study protocol (Protocol no./IRB, TCVGH No: CE18236B).". Please amend your current ethics statement to include the full name of the ethics committee/institutional review board(s) that approved your specific study. Once you have amended this/these statement(s) in the Methods section of the manuscript, please add the same text to the “Ethics Statement” field of the submission form (via “Edit Submission”). For additional information about PLOS ONE ethical requirements for human subjects research, please refer to http://journals.plos.org/plosone/s/submission-guidelines#loc-human-subjects-research. 3) Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Dear authors, here you receive my review regarding the manuscript entitled “Pain prevalence in hospitalized patients at a tertiary academic medical center: exploring severe persistent pain” with Manuscript Number: PONE-D-20-16670 and short Title: Pain prevalence in hospitalized patients. The authors present the results of a pain prevalence study based on questionnaire divided in 4 parts with special focus on demographics, pain status, pain management, and overall patient satisfaction. The study was performed within 19 wards of a tertiary referral medical center in Taiwan. The author remark on the fact that pain and pain management is not that well studied yet in some parts of Asia, in comparison with the literature in e.g. Europe. The manuscript is well written with clear understandable English language. The length is acceptable. The study was approved by an ethical review board and the number is provided. Besides the prevalence also the causes of care-related pain were surveyed. However, there are some questions remaining. The researchers seem to be trained in the execution of the questionnaire. This may be very important and could have had influence in the observed pan prevalence? We know for instance from previous studies that estimation of pain severity can be done by the patient and second best is the estimation by the responsible attending nurse taking care of the patient, when patients are unresponsive. (See, e.g., SJGM Ahlers , et al in Crit Care . 2008;12(1):R15.). What can be said about the training of the researchers? Page 12 Line 23 “Questionnaire” the internal consistency reliability …. Excellent. What can be said or shown for the reader that this aspect was judged right? P13 L18 what is meant by quota? Was there a limitation of the number of patients possible to enter the study? Were there any predetermined quota? What was the minimum or maximum number of days in retrospect that the patients were referring to regarding the experienced pain during their hospital stay? P14 L4 …longer than 4 hours…. How did the authors come to the discrimination of more or less than “4 hours”? Do they refer to any previous research or publications? P15 Table 1 It is interesting to notice that patients with severe pain 28.9% and 31.6% of all patients were male or female , respectively. Maybe not significantly different? Furthermore, when pooling the number of patients with ages from 40 till 80 31.6% of patients experienced severe pain in comparison with 30% of patients aged≤39 years of age 532 from 754 patients = 70% aged 40 to 80 years of age experienced pain. The authors found that surgery related pain was one of the serious causes of pain among this high number of patients with any pain experience, regardless the seriousness. Is i possible to be more specific on the type of surgery or type of wound pain the patients experienced with mobilization. Were there any [patients with non-surgery related pain and causes such as related to rheumatic bone and joint disease or oncology and did these numbers or prevalence differ between age groups? Interesting in table 2 page 17 is that overall 21% of patients all ages together experience a NRS4-10 for longer than 4 hours. P18 Table 3, what may be concluded or commented o “needle pain” Is this once performed in patients or in one patient repeatedly. Are there any signs that repeatedly performed panful procedures influenced the severity of pain longitudinally? P19 “Discussion” The authors refer to the study of Fabbian et al with a prevalence of 7.% of patients with severe. Please try to improve your comment regarding your observation of approx.. 21% prevalence (pooled ages), which is extremely higher? Severe pain ages <39 years old of 30% and ages 40-80 was 31.6. This differs from the reference 9. How many patients had already pain before hospitalization, for how long a period and was pain the main reason for admittance to the hospital? Did this influence your results? This may be important as pain experienced in the hospital, as a result of the treatment, diagnostic procedures as well as mobilization, superimposed on already present pain may be more severe within the patient with an already triggered pain system. P 20 L1 the word pan must be changed into pain P20 L8 Cognitive impairment….express their pain. This seems very important to me. What could be concluded from this feature in your cohort, what is the influence on patient report. This also refers to the lines 5 and 6 on p22. P19 and 20 We found…., but not a factor (Table2). Please explain? What is a possible explanation? Is there e.g. an influence from perioperative surgery and anaesthesia driven perioperative pain protocols or pain management programmes during the first 24 hours after surgery ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: dr Peter Bruins, MD, PhD, EDIC [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Pain prevalence in hospitalized patients at a tertiary academic medical center: exploring severe persistent pain PONE-D-20-16670R1 Dear Dr. Yeh, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Yan Li Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #2: (No Response) ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #2: (No Response) ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #2: (No Response) ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #2: No |
| Formally Accepted |
|
PONE-D-20-16670R1 Pain prevalence in hospitalized patients at a tertiary academic medical center: exploring severe persistent pain Dear Dr. 葉: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Yan Li Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .